Title : Aberrant glomerular filtration of urokinase-type plasminogen activator in nephrotic syndrome leads to amiloride-sensitive plasminogen activation in urine.

Pub. Date : 2015 Aug 1

PMID : 25972510






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Aberrant glomerular filtration of urokinase-type plasminogen activator in nephrotic syndrome leads to amiloride-sensitive plasminogen activation in urine. Amiloride plasminogen activator, urokinase Homo sapiens
2 The ENaC blocker amiloride is an off-target inhibitor of urokinase-type plasminogen activator (uPA) in vitro. Amiloride plasminogen activator, urokinase Homo sapiens
3 The ENaC blocker amiloride is an off-target inhibitor of urokinase-type plasminogen activator (uPA) in vitro. Amiloride plasminogen activator, urokinase Homo sapiens
4 It was hypothesized that uPA is abnormally filtered to preurine and is inhibited in urine by amiloride in nephrotic syndrome. Amiloride plasminogen activator, urokinase Homo sapiens
5 Amiloride inhibits urine uPA activity which attenuates plasminogen activation and urine protease activity in vivo. Amiloride plasminogen activator, urokinase Homo sapiens
6 Urine uPA is a relevant target for amiloride in vivo. Amiloride plasminogen activator, urokinase Homo sapiens